Stimcell Energetics, Inc.

OTC: STME · Healthcare · Medical - Devices

Canadian filerHQ Vancouver, BCCIK 0001493712Reports USD

#1143 of 1,394 Healthcare companies by revenuebottom-decile growth

EA Score

20D

FH 8DQ 22GM 45SS 34

v0.1 · 65/100 weight · provisional

↑ growth stability, listing tenure · ↓ workforce scale, revenue growth (YoY)

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$566.3k

Employees

Market cap

$6.6M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02024

Net income-$566.3k-$566.3k2025

Total assets$21.2k$21.2k2025

Liabilities$1.3M$1.3M2025

Equity-$1.2M-$1.2M2025

Revenue trend

FY2012 – FY2024 · USD

FY12

$36.6k

FY17

$6.2k

FY17

FY20

$95.8k

FY20

$2.8k

FY24

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Stimcell Energetics, Inc. booked $0 in FY2024 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

Imagion Biosystems Limited——Standard Dental Labs Inc.——PreveCeutical Medical Inc.——Sweet Earth Holdings Corporation22D

Key facts

CEODavid Jeffs

SectorHealthcare

IndustryMedical - Devices

HeadquartersVancouver, BC

ExchangeOTC: STME

Employees1

IPO date2013-08-29

Latest filings

10-Q2026-04-10 8-K2026-03-20 10-Q2026-01-15 8-K2025-12-02 10-Q2025-10-14 10-K2025-09-02 10-Q2025-04-14 8-K2025-03-28

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.